user

A phase I trial of weekly topotecan and carboplatin in potentially platinum sensitive ovarian and peritoneal carcinoma.

被引：0
|
作者：
Smrekar, M
Buller, RE
Haba, P
Visser, C
Rose, PG
机构：
[1] Hillcrest Hosp, Mayfield Hts, OH USA
[2] GlaxoSmithKline, Philadelphia, PA USA
[3] Metrohlth Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5147
引用
收藏
页码：485S / 485S
页数：1
相关论文
共 50 条
  • [41] Phase II trial of weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: Preliminary results including prevention of carboplatin hypersensitivity.
    Kushner, DM
    Hartenbach, EM
    Sanchez, F
    Schink, JC
    Connor, JP
    Bailey, HH
    Harris, LS
    Stewart, SL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 459S - 459S
  • [42] A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum
    Brown, J. V., III
    Rettenmaier, M. A.
    Lopez, K. L.
    Graham, C.
    Micha, J. P.
    Goldstein, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 249 - 254
  • [43] Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma
    Kose, M. Faruk
    Meydanli, M. Mutlu
    Tulunay, Gokhan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 437 - 443
  • [44] Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
    William, William N., Jr.
    Lee, Joseph L.
    Shin, Dong M.
    Hong, Waun K.
    Liu, Suyu
    Lee, J. Jack
    Lippman, Scott M.
    Khuri, Fadlo R.
    Kim, Edward S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 15 - 19
  • [45] Paclitaxel/carboplatin, followed by Topotecan in advanced ovarian cancer, a phase I study
    Sadozye, A
    Chan, S
    Carmichael, J
    BRITISH JOURNAL OF CANCER, 1999, 80 : 106 - 106
  • [46] Phase I-II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in esophageal carcinoma.
    D'Addario, G
    Morant, R
    Cerny, T
    ANNALS OF ONCOLOGY, 2000, 11 : 91 - 91
  • [47] Early results of a phase I study of weekly topotecan (T) in combination with weekly platinum compounds.
    White, LA
    Sjak-Shie, NN
    Kimminau, C
    Schmidt, AM
    Greco, AO
    Eckardt, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 159S - 159S
  • [48] A phase I trial of topotecan and sorafenib for patients with recurrent, platinum-resistant epithelial ovarian cancer
    Matei, Daniela E.
    Schilder, Jeanne
    Perkins, Susan
    Khan, Mohammad
    Calley, Cynthia
    Menning, Nancy
    Sutton, Gregory
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [49] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Matulonis, Ursula
    Berlin, Suzanne
    Lee, Hang
    Whalen, Christin
    Obermayer, Elizabeth
    Penson, Richard
    Liu, Joyce
    Campos, Susana
    Krasner, Carolyn
    Horowitz, Neil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 417 - 423
  • [50] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Ursula Matulonis
    Suzanne Berlin
    Hang Lee
    Christin Whalen
    Elizabeth Obermayer
    Richard Penson
    Joyce Liu
    Susana Campos
    Carolyn Krasner
    Neil Horowitz
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 417 - 423
12345